Sponsor Pipeline

Changchun GeneScience Pharmaceutical Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
20
Active Trials
12
Recruiting
1
Phase 3
2
Disease Areas
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-28 NCT07407504
GenSci145 as Monotherapy or in Combination Therapy, in Participants With PIK3CA-mutated…
Recruitment opened
2026-05-28 NCT07534176
To Evaluate the Impact of Smoking on PK After Single-dose Oral Administration of GS1-144…
Recruitment opened
2026-05-23 NCT07423533
Phase IIb Clinical Study to Assess the Efficacy and Safety of GenSci120 Injection in…
Recruitment opened
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-06-10 NCT07638800 Phase 1 Clinical Study of GenSci155 Injection in Healthy Adults Phase 1 Not Yet Recruiting
Active Trials by Phase
Phase 3
1
Phase 2
3
Phase 1/2
2
Phase 1
13
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07356037 Nanocrystalline Megestrol Acetate for Cachectic Stage Locally Advanced Hepatocellular… Cachexia Not Yet Recruiting
Phase 2
NCT07260500 A Phase II Study of PEG-rhGH Injection for Short Children Born Small for Gestational Age… Short Stature Children Born Small for Gestational Age (SGA) Recruiting
NCT07423533 Phase IIb Clinical Study to Assess the Efficacy and Safety of GenSci120 Injection in… Rheumatoid Arthritis Recruiting
NCT07547995 A Study of Efficacy and Safety of GenSci048 in Subjects With Active Uveitis. Uveitis Not Yet Recruiting
Phase 1/2
NCT07450001 A Study of GenSci134 in Children With Growth Hormone Deficiency (PGHD) Pediatric Growth Hormone Deficiency Not Yet Recruiting
NCT07450053 A Study (Phase 1b/2) of GenSci134 in Children With Idiopathic Short Stature (ISS) Idiopathic Short Stature Not Yet Recruiting
Phase 1
NCT06908434 A Phase I First-in-Human Study of GenSci128 in Patients With Solid Tumors Harboring a… Solid Tumors Harboring a TP53 Y220C Mutation Recruiting
NCT07252414 GenSci143 in Participants With Advanced Solid Tumors Advanced Solid Tumors Recruiting
NCT06569758 A Study of GenSci098 in Subjects With Active Thyroid Eye Disease Safety Recruiting
NCT07286656 A Study of GensSci098 in Subjects With Graves' Disease Safety Recruiting
NCT07473570 A Study(Phase I)of GS3-007a Dry Suspension in Healthy Chinese Adults Healthy Adults Recruiting
NCT07366866 A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci136 in Healthy Adults. Autoimmune Disease Recruiting
NCT07016802 A Clinical Study of GenSci134 in Healthy Adults and Adult Growth Hormone Deficiency(AGHD) Safety Recruiting
NCT07476586 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics of GenSci161 in Healthy… Healthy Volunteers Recruiting
NCT07407504 GenSci145 as Monotherapy or in Combination Therapy, in Participants With PIK3CA-mutated… Locally Advanced or Metastatic Solid Tumors With PIK3CA-mutated Recruiting
NCT07534176 To Evaluate the Impact of Smoking on PK After Single-dose Oral Administration of GS1-144… Postmenopause Recruiting
NCT07491289 GS1-144 in Participants With Hepatic Impairment and Healthy Female Hepatic Impairment and Healthy Female Not Yet Recruiting
NCT07537231 A Clinical Study to Evaluate the Absorption, Metabolism, and Excretion of Oral… Healthy Postmenopausal Women Active, Not Recruiting
NCT07638800 Phase 1 Clinical Study of GenSci155 Injection in Healthy Adults Healthy Adult Trial Participants Not Yet Recruiting
Not specified
NCT07553728 Safety and Efficacy of Corifollitropin Alfa N02 Injection in Elderly Women Undergoing… Infertility Not Yet Recruiting
Disease Areas
Get alerts when Changchun GeneScience Pharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free